First-time use of bevacizumab for metastatic hepatocellular carcinoma in a HIV/HBV coinfected patient.<br /> A case report

Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2008, Vol 25, Issue 5

Abstract

A case of a HIV-1 infected patient with history of chronic hepatitis B and chronic alcohol use without cirrhosis, who presented with aggressive hepatocellular carcinoma (HCC) with multiple metastasis is presented. Systemic chemotherapy combined with use of bevacizumab (anti-VEGF monoclonal antibody) was without effect and the patient succumbed to his disease within weeks. Relatively recent data indicate that HCC may be extremely aggressive in HIV/HBV or HIV/HCV coinfected patients with younger age at presentation, shorter evolution time, a more advanced stage at presentation with higher rates of extrahepatic-extranodal metastases and, finally, a reduced survival rate as compared with HIV-negative patients. To our knowledge, this is the first report in the English literature of bevacizumab use for metastatic hepatocellular carcinoma in HIV infected patients.

Authors and Affiliations

I. BARABOUTIS, G. CHARITSIS, V. PAPASTAMOPOULOS, L. LEKAKIS, M. VASLAMATZIS, A. SKOUTELIS

Keywords

Related Articles

The association of serum leptin with biochemical parameters of bone turnover in maintenance hemodialysis patients

OBJECTIVE Leptin is a small peptide hormone that is mainly, but not exclusively, produced in adipose tissue and cleared principally by the kidney. Serum leptin concentrations and bone mass are directly related. This cros...

The beneficial effect of increased dietary fiber intake in chronic constipation, and irritable bowel syndrome and on the incidence of colorectal polyps and cancer: Myth or reality?

Despite the fact that the presence of fibers in the diet has long been recognized, their role in the prevention of various diseases of the gastrointestinal tract still breeds controversy, mainly because a high-fiber diet...

Histological changes of the aortic wall under mechanical stress

OBJECTIVE It is known that the aorta responds to changes in intraluminal pressures by changes in its dimensions. The aim of this study was the investigation of the structural-histological remodeling of the aortic wall as...

Cost-effectiveness analysis of atorvastatin compared to simvastatin treatment in Greece

OBJECTIVE To determine the cost-effectiveness of treatment with atorvastatin compared to simvastatin, generically priced, in achieving the NCEP ATP III LDL-cholesterol target levels in Greece. METHOD To compare atorv...

AML, M5 type, -Beau Lines

A 35-year-old woman presented to the outpatient dep artment because of fever during the last fifteen days and symptoms from the upper respiratory tract. She was treated with trimethoprim/ sulphamethoxazole and the fe...

Download PDF file
  • EP ID EP102207
  • DOI -
  • Views 100
  • Downloads 0

How To Cite

I. BARABOUTIS, G. CHARITSIS, V. PAPASTAMOPOULOS, L. LEKAKIS, M. VASLAMATZIS, A. SKOUTELIS (2008). First-time use of bevacizumab for metastatic hepatocellular carcinoma in a HIV/HBV coinfected patient.<br /> A case report . Αρχεία Ελληνικής Ιατρικής, 25(5), 636-636. https://www.europub.co.uk/articles/-A-102207